Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Net Margin (2016 - 2025)

Macrogenics (MGNX) has disclosed Net Margin for 14 consecutive years, with 34.33% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 422.0% to 34.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 51.04% through Dec 2025, down 833.0% year-over-year, with the annual reading at 49.91% for FY2025, 526.0% down from the prior year.
  • Net Margin for Q4 2025 was 34.33% at Macrogenics, down from 23.09% in the prior quarter.
  • The five-year high for Net Margin was 50.86% in Q3 2024, with the low at 1686.79% in Q2 2024.
  • Average Net Margin over 5 years is 303.71%, with a median of 233.42% recorded in 2025.
  • The sharpest move saw Net Margin plummeted -133861bps in 2024, then soared 152380bps in 2025.
  • Over 5 years, Net Margin stood at 411.65% in 2021, then skyrocketed by 104bps to 16.39% in 2022, then plummeted by -2908bps to 460.39% in 2023, then soared by 92bps to 38.55% in 2024, then rose by 11bps to 34.33% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 34.33%, 23.09%, and 162.99% for Q4 2025, Q3 2025, and Q2 2025 respectively.